ARCHIVES

Texas Oncology Designated Aranesp As Preferred Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

September 26, 1980

NCI Programs: Unequal Outcomes For Minorities The Result of Unequal Treatment NCI Suggests Awareness Campaign

December 17, 1999

Medline Plus Provides Info To Patients About Prescriptions

May 28, 2004

NHGRI Director Francis Collins To Step Down.

May 30, 2008

Health Disparities Between Minorities Too Large, Shalala Says

March 27, 1998

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983